latest news on glp 1 GLP-1 Pipeline Update: August 2025 - Prime Therapeutics

Glucagon-Like Peptide-1 Receptor Agonists in Perioperative Care

27.85

★★★★☆4.8 (126)

GLP-1 analogs, new trend in obesity treatment, become even more effective < Pharma < Article

28.94

★★★★★4.9 (98)

GLP-1 Receptor Agonists Show Promise in ASCO 2026 Research

27.57

★★★★★5.0 (157)

New study reveals why patients stop taking GLP-1 obesity drugs

23.60

★★★★★4.7 (84)

Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating

24.58

★★★★★4.9 (203)

Review suggests most GLP-1 users regain weight within two years after stopping

21.05

★★★★★5.0 (176)

New real-world data show that over half of people who stop GLP-1 weight-loss drugs regain some weight within a year. The findings align with clinical trial data: once treatment stops, weight typically

25.12

★★★★★4.8 (132)